Lung function trajectory in progressive fibrosing interstitial lung disease
Justin M. Oldham(Michigan Medicine), Philip L. Molyneaux(Guy's and St Thomas' NHS Foundation Trust), Janelle Vu Pugashetti(Michigan Medicine), Gabrielle Echt(University of California, Davis), Nam Huu Đao(University of California, Davis), Christine Kim Garcia(NewYork–Presbyterian Hospital), Felix Chua(Royal Brompton Hospital), Toby M. Maher(University of Southern California), Chad A. Newton(The University of Texas Southwestern Medical Center), Hasan Seede(The University of Texas Southwestern Medical Center), Ayodeji Adegunsoye(University of Chicago), Mary E. Strek(University of Chicago), Zhe Wu(Guy's and St Thomas' NHS Foundation Trust), Willis S. Bowman(University of California, Davis), James Tonkin(Royal Brompton Hospital), Cathryn T. Lee(University of Chicago)
Cited by 123
Related Papers
Pulmonary fibrosis secondary to COVID-19: a call to arms?
|The Lancet Respiratory Medicine|2020|498
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
<i>TOLLIP</i> , <i>MUC5B</i> , and the Response to <i>N</i> -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2015|358
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
|The Lancet Respiratory Medicine|2017|299